The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses

Crystal A. Mendoza, Satoko Yamaoka, Yoshimi Tsuda, Keita Matsuno, Carla M. Weisend, Hideki Ebihara

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases